SCHEMBL206244

SCHEMBL206244

NC(=O)c1cccc2oc(-c3ccncc3)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 4/20 0.52
PKN2 Q16513 4/20 0.52
PLK4 O00444 1/20 0.52
MAPK13 O15264 1/20 0.52
DYRK3 O43781 1/20 0.52
ROCK2 O75116 1/20 0.52
RPS6KA5 O75582 1/20 0.52
PRKD3 O94806 1/20 0.52
MAP4K4 O95819 1/20 0.52
CHEK2 O96017 1/20 0.52
PIM1 P11309 1/20 0.52
PHKG2 P15735 1/20 0.52
PRKACA P17612 1/20 0.52
RPS6KB1 P23443 1/20 0.52
CSNK1D P48730 1/20 0.52
CLK2 P49760 1/20 0.52
GSK3A P49840 1/20 0.52
PRKX P51817 1/20 0.52
PRKCZ Q05513 1/20 0.52
STK3 Q13188 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2961027 0.88 TOP2A (0.54) TOP2AKDM4EALDH1A1RXFP1POLB
SCHEMBL204764 0.88 TOP2A (0.61) PARP1PARP2TOP2AKDM4EALDH1A1
SCHEMBL3710917 0.86 TOP2A (0.58) PARP1TOP2AKDM4EALDH1A1HPGD
SCHEMBL206525 0.86 PARP1 (0.52) PARP1TOP2AKDM4EALDH1A1RXFP1
SCHEMBL205783 0.85 IKBKB (0.56) PKN1PKN2MKNK2PARP1PARP2
SCHEMBL206391 0.84 PARP1 (0.53) MAP4K4PARP1PARP2TOP2ARXFP1
SCHEMBL206074 0.84 TOP2A (0.51) TOP2AKDM4EALDH1A1RXFP1POLB
SCHEMBL205454 0.84 TOP2A (0.48) RPS6KB1PARP1TOP2AKDM4EALDH1A1
SCHEMBL206399 0.84 HTR3A (0.53) PARP1TOP2AKDM4EALDH1A1HPGD
SCHEMBL204524 0.84 PARP1 (0.53) PARP1TOP2AKDM4EALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088760-B2 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) BIOMARIN PHARMACEUTICAL INC. (US) 2012-01-03 US claimed
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-06 US claimed
US-8088760-B2 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) BIOMARIN PHARMACEUTICAL INC. (US) 2012-01-03 US disclosed
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) PARP1, PARP2, PARP11 PKN1 1081/4885PKN2 901/4885PLK4 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.